Stevie Yu

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.

Cooley advised Midwestern Electric, a portfolio company of Canada-based private equity firm CAI Capital Partners and a provider of electrical infrastructure services, on its acquisition of Kuharchik Construction and Wyoming Electric & Signals.

Cooley advised Ionis Pharmaceuticals, a biotechnology company, in its $575 million aggregate principal amount of convertible senior notes.

Cooley advised Mirum Pharmaceuticals on its $275 million aggregate principal amount of 4.00% convertible senior notes due 2029. Mirum is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Jason Kent and Jason Savich led the Cooley team.